Journal Article Review Research Support, Non-U.S. Gov't Epublish 27 citations
PubMed: 35741059 DOI: 10.3390/cells11121930
Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA.
Cells 11(12)
Authors: Michele Salemi, Maria Paola Mogavero, Giuseppe Lanza, Laura M MongioƬ, Aldo E Calogero, Raffaele Ferri
Affiliations
- Oasi Research Institute, IRCCS (Istituti di Ricovero e Cura a Carattere Scientifico), Italian Ministry of Health, 94018 Troina, Italy.
- Istituti Clinici Scientifici Maugeri, IRCCS (Istituti di Ricovero e Cura a Carattere Scientifico), Scientific Institute of Pavia, 27100 Pavia, Italy.
- Department of Surgery and Medical-Surgical Specialties, University of Catania, 95123 Catania, Italy.
- Department of Clinical and Experimental Medicine, University of Catania, 95123 Catania, Italy.
Abstract
Cancer is one of the most common causes of death; in parallel, the incidence and prevalence of central nervous system diseases are equally high. Among neurodegenerative diseases, Alzheimer's dementia is the most common, while Parkinson's disease (PD) is the second most frequent neurodegenerative disease. There is a significant amount of evidence on the complex biological connection between cancer and neurodegeneration. Noncoding RNAs (ncRNAs) are defined as transcribed nucleotides that perform a variety of regulatory functions. The mechanisms by which ncRNAs exert their functions are numerous and involve every aspect of cellular life. The same ncRNA can act in multiple ways, leading to different outcomes; in fact, a single ncRNA can participate in the pathogenesis of more than one disease-even if these seem very different, as cancer and neurodegenerative disorders are. The ncRNA activates specific pathways leading to one or the other clinical phenotype, sometimes with obvious mechanisms of inverse comorbidity. We aimed to collect from the existing literature examples of inverse comorbidity in which ncRNAs seem to play a key role. We also investigated the example of mir-519a-3p, and one of its target genes Poly (ADP-ribose) polymerase 1, for the inverse comorbidity mechanism between some cancers and PD. We believe it is very important to study the inverse comorbidity relationship between cancer and neurodegenerative diseases because it will help us to better assess these two major areas of human disease.
MeSH
Comorbidity, Cells, Neoplasms, Genes, Neurodegenerative Diseases, Rna, Untranslated, Poly Adenosine Diphosphate Ribose, Poly(Adp-Ribose) Polymerases
Cited by
- Sleep Disorders: Pathogenesis and Therapeutic Interventions. MedComm (2020), 2025
- Role and Dysregulation of miRNA in Patients with Parkinson's Disease. Int J Mol Sci, 2023
- Cellular Metabolism: A Fundamental Component of Degeneration in the Nervous System. Biomolecules, 2023
- Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis. iScience, 2024
- Implications of TDP-43 in non-neuronal systems. Cell Commun Signal, 2023
- Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations. Nat Sci Sleep, 2023
- Double Trouble: Association of Malignant Melanoma with Sporadic and Genetic Forms of Parkinson's Disease and Asymptomatic Carriers of Related Genes: A Brief Report. Medicina (Kaunas), 2023
- Potential role of TNFRSF12A in linking glioblastoma and alzheimer's disease via shared tumour suppressor pathways. Sci Rep, 2025
- Timing of risk factors, prodromal features, and comorbidities of dementia from a large health claims case-control study. Alzheimers Res Ther, 2025
- A mouse model of MEIS1-associated restless legs syndrome: insights and challenges. Sleep, 2024
- The Triad of Sleep, Immunity, and Cancer: A Mediating Perspective. Cells, 2024
- A Theoretical and Practical Analysis of Membrane Protein Genes Altered in Neutrophils in Parkinson's Disease. Curr Issues Mol Biol, 2025
- The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk. Front Immunol, 2023
- Gene Expression Profiling of Post Mortem Midbrain of Parkinson's Disease Patients and Healthy Controls. Int J Mol Sci, 2024